Research breakthroughs, institutional announcements, policy responses, and scientific commentary from KEMRI's scientists and leadership โ the authoritative voice on Kenyan health science.
A landmark publication from KEMRI's Centre for Virus Research has appeared in Nature Microbiology โ the institute's first paper in one of the world's most prestigious microbiology journals. The study characterises three novel respiratory pathogen lineages identified through Kenya's national genomic surveillance network, with implications for both regional public health preparedness and global disease intelligence.
Read Full Story โThe World Health Organisation has formally designated KEMRI's Centre for Virus Research as a WHO Collaborating Centre, recognising Kenya's genomic surveillance capacity as a continental reference point.
A new memorandum of understanding will see KEMRI researchers embedded in five Nairobi county health facilities, conducting real-time health systems research directly within the capital's public health infrastructure.
A Phase II clinical trial conducted at KEMRI's Centre for Global Health Research in Kisumu has demonstrated significant protective efficacy for a next-generation malaria vaccine candidate targeting high-transmission settings.
KEMRI's 2023 Annual Report documents a record 340 peer-reviewed publications, the opening of two new field research stations in northern Kenya, and significant expansion of the genomic sequencing facility in Nairobi.
KEMRI's Principal Investigator for Genomic Surveillance has been honoured by Africa CDC for his contribution to building continental pathogen sequencing capacity during and after the COVID-19 pandemic.
Seasonal respiratory disease surveillance findings from KEMRI's sentinel network have been incorporated directly into the Ministry of Health's updated clinical and public health response guidelines for 2024.
A plant-derived compound isolated by KEMRI's Centre for Traditional Medicine has demonstrated potent activity against multiple drug-resistant bacterial strains, advancing to formal preclinical safety and efficacy testing.
KEMRI's genomic sequencing infrastructure has been formally integrated into Africa CDC's continental pathogen genomics network, extending KEMRI's surveillance reach across 11 partner countries.
The KEMRI Board of Directors has confirmed the appointment of Dr. Elias Macharia as Director General, succeeding the outgoing leadership after a competitive national recruitment process.
KEMRI's communications team is available to respond to media enquiries, provide expert comment, and arrange interviews with our scientists.